Anti-PORCN monoclonal antibody Made to order

Focal dermal hypoplasia ( FDH) is an X- linked dominant multisystem birth defect affecting tissues of ectodermal and mesodermal origin. Using a stepwise approach of ( i) genetic mapping of FDH, ( ii) high- resolution comparative genome hybridization to seek deletions in candidate chromosome areas and ( iii) point mutation analysis in candidate genes, we identified PORCN, encoding a putative O- acyltransferase and potentially crucial for cellular export of Wnt signaling proteins, as the gene mutated in FDH. The findings implicate FDH as a developmental disorder caused by a deficiency in PORCN.

Wnt signaling controls early embryonic hematopoiesis and dysregulated beta-catenin is implicated in leukemia. However, the role of Wnts and their source in adult hematopoiesis is still unclear, and is clinically important as upstream Wnt inhibitors enter clinical trials. We blocked Wnt secretion in hematopoietic lineages by targeting Porcn, a membrane-bound O-acyltransferase that is indispensable for the activity and secretion of all vertebrate Wnts. Surprisingly, deletion of Porcn in Rosa-CreER(T2) /Porcn(Del), MX1-Cre/Porcn(Del), andVav-Cre/Porcn(Del) mice had no effects on proliferation, differentiation, or self-renewal of adult hematopoietic stem cells. Targeting Wnt secretion in the bone marrow niche by treatment with a PORCN inhibitor, C59, similarly had no effect on hematopoiesis. These results exclude a role for hematopoietic PORCN-dependent Wnts in adult hematopoiesis. Clinical use of upstream Wnt inhibitors is not likely to be limited by effects on hematopoiesis.